Faecal Extraction Systems Market Growth Drivers, Emerging Trends And Future Outlook By 2024-2033

The faecal extraction systems market size has grown steadily in recent years. It will grow from $1.64 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to ethical concerns and stringent regulations, economic conditions, disruption in research activities, impact of covid-19, increased prevalence of inflammatory bowel disease (ibd).

The faecal extraction systems market size is expected to see steady growth in the next few years. It will grow to $2.04 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to sustainable recovery, regional dominance, government support and research investments, post-covid recovery. Major trends in the forecast period include product innovations, marketing strategies and channels, market players, economic conditions, technological innovations.

Market Overview -
A faecal extraction system is a device or instrument that collects faeces samples to identify pathogens, microbes, or parasite particles that could be present inside the stool.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=8297&type=smp

The Impact Of Rising Inflammatory Bowel Disease Prevalence On The Faecal Extraction Systems Market
The increasing prevalence of inflammatory bowel disease is expected to propel the growth of the faecal extraction systems market going forward. Inflammatory bowel disease (IBD) is a category of illnesses characterised by long-term (chronic) inflammation of digestive system tissues. Faecal extraction systems are used for the diagnosis, monitoring of disease activity, treatment guidance, and prediction of disease relapse and post-operative recurrence in inflammatory bowel disease, as a result, the increasing prevalence of inflammatory bowel disease increases the demand for faecal extraction systems. For instance, in May 2021, according to a report published by BioMed Central, a UK-based journal, the prevalence of Inflammatory Bowel Disease (IBD) is expected to significantly increase in various regions in 2035. Iran is projected to experience a 2.5-fold rise, reaching 69 thousand cases. In North Africa and the Middle East, the prevalence is estimated to increase by 2.3-fold, totalling 220 thousand cases. Moreover, there is an anticipation of a fourfold increase in prevalence in India, totalling 2.2 million cases. Therefore, the increasing prevalence of inflammatory bowel disease in faecal extraction systems is expected drives the growth of the faecal extraction systems market.

Competitive Landscape -
Major companies operating in the faecal extraction systems market report are American Laboratory Products Co. Ltd., Alpha Laboratories Ltd., Arbor Assays, bioMérieux SA, Buhlmann Laboratories AG, Calpro AS, Cancax Biotech SL, DRG Instruments GmbH, Promega Corporation, Werfen SA, Mobidiag Oy, AutoGen Inc., Microbiome Research Pvt. Ltd., Biohit Healthcare Ltd., Meridian Bioscience Inc., Quidel Corporation, DiaSorin SpA, Sekisui Diagnostics LLC, Hologic Inc., Abbott Laboratories, Roche Diagnostics Corporation, Siemens Healthineers, Beckman Coulter Inc., Cepheid Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GenMark Diagnostics Inc., Luminex Corporation, Nanosphere Inc., OraSure Technologies Inc., QIAGEN NV, Quest Diagnostics Incorporated, Randox Laboratories Ltd., Sysmex Corporation, Thermo Fisher Scientific Inc., Trinity Biotech plc

Major Companies Introduce Fecal Dna Tests For Enhanced Colorectal Cancer Detection In The Faecal Extraction System Market
Major companies operating in the faecal extraction system market are developing innovative products such as fecal DNA tests to meet larger customer bases, more sales, and increase revenue. Fecal DNA tests refer to non-invasive diagnostic procedures that analyze DNA extracted from a person's stool sample. For instance, in March 2023, BGI Genomics, a China-based biotechnology company, together with Zentya, a Slovakia-based prominent provider in the field of genetic screening, launched COLOTECT 1.0. Distinguishing itself as one of the pioneering fecal DNA tests for colorectal cancer in Slovakia, COLOTECT 1.0 stands out for its non-invasive nature and ability to detect colorectal cancer and precancerous lesions. The test employs multiplex methylation-specific PCR technology, enabling the identification of abnormal colorectal cancer DNA-methylation biomarkers from fecal samples.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/faecal-extraction-systems-global-market-report

Key Segments -
The faecal extraction systems market covered in this report is segmented -
1) By Assay: Calprotectin, Albumin, Haemoglobin, Bile Acids
2) By Analysis Test: Microscopic, Chemical, Immunological, Microbiological
3) By Indication: Parasitic Infection, Viral Infection, Bacterial Indication, Poor Nutrient Absorption
4) By End-Use: Diagnostic Centers, Hospitals & Clinics, Ambulatory Clinics, Research Centers

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.